The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD
International Journal of Molecular Sciences · 20.06.2025 · 26 (13) · 5929
DOI: 10.3390/ijms26135929 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.06.2025. Verfasst von Anna Dorota Grzesińska. Beteiligte Einrichtung: Collegium Medicum, Jan Dlugosz University in Czestochowa, ul. Waszyngtona 4/8, 42-200 Częstochowa, Poland. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Endocannabinoids, Glutamic Acid, gamma-Aminobutyric Acid. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development, National Center for Research and Development, ERA-Net Neuron.
Abstract (Originalsprache)
Post-traumatic stress disorder (PTSD) is a debilitating mental health condition that develops in response to traumatic events. The endocannabinoid, glutamatergic, and GABAergic systems play crucial roles in the neurobiological mechanisms of PTSD. Both the endocannabinoid, glutamatergic, and GABAergic systems are involved in synaptic remodeling and neuronal differentiation, ensuring efficient information transmission in the brain. Their interplay influences motivation, behavior, sensory perception, pain regulation, and visual processing. Additionally, these systems regulate processes such as cellular proliferation, adhesion, apoptosis, and immune responses. This article explores the involvement of the endocannabinoid, glutamatergic, and GABAergic systems in PTSD pathogenesis. A literature review was conducted on studies examining the relationship between the endocannabinoid, glutamatergic, and GABAergic systems in PTSD. Relevant publications were sourced from the Web of Science and Scopus databases, covering research up to 29 February 2025. Neurobiological mechanisms underlying PTSD may share common pathways with other mental and somatic disorders, particularly those involving inflammatory processes. The identification of biomarkers is crucial for assessing PTSD risk and implementing targeted interventions to improve patient outcomes. A deeper understanding of these mechanisms could enhance therapeutic strategies, ultimately improving the quality of life for individuals affected by PTSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collegium Medicum, Jan Dlugosz University in Czestochowa, ul. Waszyngtona 4/8, 42-200 Częstochowa, Poland.
ORCID-Profile: Anna Dorota Grzesińska
Förderung
- National Centre for Research and Development
- National Center for Research and Development
- ERA-Net Neuron
Zitieren
APA
Grzesińska, A. D. (2025). The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD. International Journal of Molecular Sciences, 26(13), 5929. https://doi.org/10.3390/ijms26135929
Vancouver
Grzesińska AD. The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD. International Journal of Molecular Sciences. 2025;26(13):5929. doi:10.3390/ijms26135929
BibTeX
@article{Grzesiska2025,
author = {Grzesińska, Anna Dorota},
title = {The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {5929},
doi = {10.3390/ijms26135929}
}
EUVIMED